BR0316563A - Fração de albumina derivada de plasma exaurido de prekallikrein - Google Patents
Fração de albumina derivada de plasma exaurido de prekallikreinInfo
- Publication number
- BR0316563A BR0316563A BR0316563-9A BR0316563A BR0316563A BR 0316563 A BR0316563 A BR 0316563A BR 0316563 A BR0316563 A BR 0316563A BR 0316563 A BR0316563 A BR 0316563A
- Authority
- BR
- Brazil
- Prior art keywords
- fraction
- prekallikrein
- plasma derived
- exhausted plasma
- exhausted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000113 Plasma Kallikrein Proteins 0.000 title abstract 2
- 102000009027 Albumins Human genes 0.000 abstract 2
- 108010088751 Albumins Proteins 0.000 abstract 2
- 108010071241 Factor XIIa Proteins 0.000 abstract 2
- 238000005194 fractionation Methods 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Obesity (AREA)
- Nutrition Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
"FRAçãO DE ALBUMINA DERIVADA DE PLASMA EXAURIDO DE PREKALLIKREIN". A presente invenção refere-se a uma fração contendo albumina tendo um reduzido teor de ativador de prekallikrein (PKA) e a um método de fabricação do mesmo, compreendendo as etapas de: (a) reconstituição da pasta V (fracionamento de Cohn); (b) execução de uma etapa de concentração da fração obtida na etapa (a); (c) aquecimento da fração obtida na etapa (b) em uma faixa de 50<198>C a 70<198>C por um período de tempo suficiente para pasteurizar a fração; e (d) opcionalmente, enchimento da fração obtida para uso.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02026165 | 2002-11-25 | ||
PCT/EP2003/013239 WO2004047859A2 (en) | 2002-11-25 | 2003-11-25 | Prekallikrein depleted plasma derived albumin fraction |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0316563A true BR0316563A (pt) | 2005-10-04 |
Family
ID=32337993
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0316563-9A Pending BR0316563A (pt) | 2002-11-25 | 2003-11-25 | Fração de albumina derivada de plasma exaurido de prekallikrein |
Country Status (23)
Country | Link |
---|---|
US (1) | US7700732B2 (pt) |
EP (1) | EP1565207B1 (pt) |
JP (1) | JP4532282B2 (pt) |
KR (1) | KR101077651B1 (pt) |
CN (1) | CN100364609C (pt) |
AT (1) | ATE322907T1 (pt) |
AU (1) | AU2003292109B2 (pt) |
BR (1) | BR0316563A (pt) |
CA (1) | CA2506848C (pt) |
DE (1) | DE60304603T2 (pt) |
DK (1) | DK1565207T3 (pt) |
ES (1) | ES2261977T3 (pt) |
IL (1) | IL168506A (pt) |
MX (1) | MXPA05005328A (pt) |
NO (1) | NO330216B1 (pt) |
PL (1) | PL375539A1 (pt) |
PT (1) | PT1565207E (pt) |
RS (1) | RS20050401A (pt) |
RU (1) | RU2321421C2 (pt) |
SI (1) | SI1565207T1 (pt) |
UA (1) | UA77596C2 (pt) |
WO (1) | WO2004047859A2 (pt) |
ZA (1) | ZA200504202B (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2221817B1 (es) | 2004-07-26 | 2005-10-01 | Probitas Pharma, S.A. | "soluciones de albumina humana terapeutica con baja actividad del activador de precalicreina (pka) y procedimiento de obtencion de las mismas". |
ES2294976B1 (es) | 2007-11-12 | 2008-12-16 | Grifols, S.A. | "procedimiento de obtencion de albumina humana de alta eficacia para su uso en terapia de detoxificacion". |
SE1050124A1 (sv) | 2010-02-08 | 2011-08-09 | Linkoping Biocontrols Ab | Stabil lösning |
GB201317458D0 (en) * | 2013-10-02 | 2013-11-13 | Spd Swiss Prec Diagnostics Gmbh | Improved pregnancy test device and method |
CN107216383A (zh) * | 2017-07-13 | 2017-09-29 | 同路生物制药有限公司 | 一种人血白蛋白的制备方法及该人血白蛋白 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4251510A (en) * | 1979-08-15 | 1981-02-17 | Cutter Laboratories, Inc. | Intravenously injectable solution of plasma protein fraction free from bradykinin, kininogen and prekallikrein activators and processes for its production |
US4378346A (en) * | 1979-08-15 | 1983-03-29 | Tankersley Donald L | Intravenously injectable solution of plasma protein fraction free from bradykinin, kininogen and prekallikrein activators and processes for its production |
US4440679A (en) * | 1980-03-05 | 1984-04-03 | Cutter Laboratories, Inc. | Pasteurized therapeutically active protein compositions |
EP0035204B2 (en) * | 1980-03-05 | 1991-05-22 | Miles Inc. | Pasteurized therapeutically active protein compositions |
US4391801A (en) * | 1981-10-29 | 1983-07-05 | Cutter Laboratories, Inc. | Plasma protein fraction substantially free of acetate ions |
AT376367B (de) * | 1983-03-16 | 1984-11-12 | Immuno Ag | Verfahren zur herstellung von therapeutisch verabreichbaren, in endbehaeltern abgefuellten plasmaderivaten |
AT391810B (de) * | 1988-02-26 | 1990-12-10 | Immuno Ag | Verwendung von chymotrypsin zum unwirksammachen des praekallikrein-aktivators |
JP3554796B2 (ja) * | 1988-10-31 | 2004-08-18 | 三菱ウェルファーマ株式会社 | アルブミン製剤及びその製造方法 |
US5919907A (en) * | 1997-12-22 | 1999-07-06 | Shanbrom Technologies Llc | Preparation and utilization of a novel sterile albumin |
US6693173B2 (en) * | 2000-12-26 | 2004-02-17 | Alpha Therapeutic Corporation | Method to remove citrate and aluminum from proteins |
-
2003
- 2003-11-25 MX MXPA05005328A patent/MXPA05005328A/es active IP Right Grant
- 2003-11-25 US US10/533,160 patent/US7700732B2/en not_active Expired - Fee Related
- 2003-11-25 EP EP03767649A patent/EP1565207B1/en not_active Revoked
- 2003-11-25 CN CNB2003801041314A patent/CN100364609C/zh not_active Expired - Fee Related
- 2003-11-25 DK DK03767649T patent/DK1565207T3/da active
- 2003-11-25 RS YUP-2005/0401A patent/RS20050401A/sr unknown
- 2003-11-25 AU AU2003292109A patent/AU2003292109B2/en not_active Ceased
- 2003-11-25 ES ES03767649T patent/ES2261977T3/es not_active Expired - Lifetime
- 2003-11-25 CA CA2506848A patent/CA2506848C/en not_active Expired - Fee Related
- 2003-11-25 PT PT03767649T patent/PT1565207E/pt unknown
- 2003-11-25 BR BR0316563-9A patent/BR0316563A/pt active Pending
- 2003-11-25 UA UAA200506246A patent/UA77596C2/uk unknown
- 2003-11-25 PL PL03375539A patent/PL375539A1/xx unknown
- 2003-11-25 RU RU2005119987/15A patent/RU2321421C2/ru not_active IP Right Cessation
- 2003-11-25 JP JP2004554458A patent/JP4532282B2/ja not_active Expired - Fee Related
- 2003-11-25 WO PCT/EP2003/013239 patent/WO2004047859A2/en active IP Right Grant
- 2003-11-25 AT AT03767649T patent/ATE322907T1/de active
- 2003-11-25 SI SI200330277T patent/SI1565207T1/sl unknown
- 2003-11-25 KR KR1020057008932A patent/KR101077651B1/ko not_active IP Right Cessation
- 2003-11-25 DE DE60304603T patent/DE60304603T2/de not_active Expired - Lifetime
-
2005
- 2005-05-10 IL IL168506A patent/IL168506A/en not_active IP Right Cessation
- 2005-05-24 ZA ZA200504202A patent/ZA200504202B/en unknown
- 2005-05-26 NO NO20052550A patent/NO330216B1/no not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20061547L (no) | Injiserbare kalsiumfosfat faste staver eller masser for levering av osteogene proteiner | |
BRPI0514411B8 (pt) | formulação, e, método de produzir uma formulação | |
DE602004031134D1 (de) | Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa | |
BR9908015A (pt) | Composições que compreendem vìrus e métodos para concentração de preparações de vìrus | |
IL172844A0 (en) | Method for stabilizing a cryoprecipitate of plasmatic proteins for being subjected to a viral inactivation thermal treatment | |
DK1660528T3 (da) | Mutein af tåre-lipocalin | |
BRPI0519705A2 (pt) | composiÇÕes, proteÍnas de fusço e mÉtodos de estimular uma resposta imune em um indivÍduo | |
ATE381323T1 (de) | Pharmazeutische zusammensetzungen enthaltend flavonoide und menthol | |
WO2004043906A3 (de) | Verwendung von trans-pellitorin als aromastoff | |
PL373465A1 (en) | Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives | |
BR0316563A (pt) | Fração de albumina derivada de plasma exaurido de prekallikrein | |
ATE354648T1 (de) | Verfahren zur herstellung eines virus inaktivierten thrombin präparates | |
ATE213937T1 (de) | Spezielle halofantrinhaltige zusammensetzungen | |
BR9906057A (pt) | Método de fabricação de composição para uso no controle de moscas frutiferas | |
BR0211245A (pt) | Alimento contendo proteìna compreendendo uma enzima de ligação cruzada e um hidrocolóide | |
NO993407L (no) | Fremstilling av proteinpreparater med nedsatt aggregatinnhold | |
DE60229234D1 (de) | Feste mischungen von alpha-hydroxycarbonylderivaten von alpha-methylstyrololigomeren und deren verwendung | |
AU2003251729A1 (en) | Use of antibodies against flt-1 for the treatment of osteoporosis | |
DE60121196D1 (de) | Verfahren zur monomerisierung von humanen serumalbumin-polymeren | |
BR0316995A (pt) | Modulação anti-sentido da expressão de mitoneet | |
UA36483A (uk) | Спосіб прогнозування перебігу процесу репаративної регенерації нижньощелепної кістки при її ушкодженнях | |
NO20060581L (no) | Fish protein hydrolyzate | |
ES2170654B1 (es) | Perfeccionamientos introducidos en el objeto de la patente p9900757, por un procedimiento para la obtencion de gammaglobulinas de origen animal y aplicaciones correspondientes. | |
BRPI0409277A (pt) | método e composição para a remodelagem, in vitro, de uma molécula de peptìdeo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |